Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing three antiretroviral combinations in asymptomatic HIV-infected individuals has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED